Pluristem Therapeutics  logo
Pluristem Therapeutics PSTI
$ 1.03 -1.9%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Pluristem Therapeutics Balance Sheet 2011-2024 | PSTI

Annual Balance Sheet Pluristem Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-1.2 M 1.02 M -2.65 M -30.5 M -6.68 M -4.11 M -8.82 M -4.71 M -6.22 M -22.6 M -4.49 M -9.01 M -30.8 M -42.8 M

Long Term Debt

5.03 M 5.75 M 6.5 M 100 K - - - - - - - - - -

Long Term Debt Current

559 K 627 K 619 K 634 K 1.02 M - - - - - - - 13 K -

Total Non Current Liabilities

29.7 M 29.9 M 29 M 24.9 M 1.44 M 1.33 M 1.9 M 1.87 M 2.01 M 3.83 M 4.5 M 4.93 M 4.16 M 576 K

Total Current Liabilities

4.45 M 5.62 M 6.83 M 11.5 M 7.99 M 8.16 M 8.55 M 5.41 M 5.78 M 6.18 M 7.4 M 5.92 M 5.52 M -

Total Liabilities

- - - - 9.43 M 9.49 M 10.5 M 7.28 M 7.78 M 10 M 11.9 M 10.8 M 9.68 M 2.59 M

Deferred Revenue

- - - 40 K 126 K - 640 K - - 472 K 626 K 772 K 792 K -

Retained Earnings

-420 M -400 M -371 M -330 M -280 M -251 M -216 M -190 M -162 M -139 M -114 M -86.9 M -65.7 M -51 M

Total Assets

39.5 M 50.8 M 68.1 M 93.5 M 65.5 M 31.3 M 39 M 37.5 M 45.9 M 68.2 M 74 M 68.3 M 47.4 M 46 M

Cash and Cash Equivalents

6.78 M 5.36 M 9.77 M 31.2 M 8.27 M 4.11 M 8.82 M 4.71 M 6.22 M 22.6 M 4.49 M 9.01 M 9.39 M 42.8 M

Book Value

39.5 M 50.8 M 68.1 M 93.5 M 56.1 M 21.8 M 28.5 M 30.3 M 38.2 M 58.1 M 62.1 M 57.5 M 37.7 M 43.4 M

Total Shareholders Equity

96 K 13.4 M 30 M 57.2 M 56.1 M 21.8 M 28.5 M 30.3 M 38.2 M 58.1 M 62.1 M 57.5 M 37.7 M 43.4 M

All numbers in USD currency

Quarterly Balance Sheet Pluristem Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

4.94 M 5.03 M 5.4 M 5.43 M 5.75 M 6.03 M 6.24 M 6.3 M 6.5 M 7.27 M 7.61 M 94 K 100 K 100 K 159 K 385 K 1.26 M 1.26 M 1.26 M 1.26 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

30.9 M 29.7 M 30.4 M 29.2 M 29.9 M 30 M 29.7 M 27.8 M 29 M 31.2 M 31.7 M 24.5 M 24.9 M 24.9 M 1.12 M 1.66 M 1.44 M 1.44 M 1.96 M 2.2 M 1.33 M 1.33 M 1.88 M 1.97 M 1.9 M 1.94 M 1.98 M 1.82 M 1.87 M 1.87 M 1.81 M 1.93 M 2.01 M 2.01 M 2.08 M 3.72 M 3.83 M 3.83 M 4.03 M 4.15 M 4.5 M 4.5 M 4.92 M 4.96 M 4.93 M 4.93 M 3.95 K 4.02 M 4.16 M 4.16 M 4.31 M 4.5 M 576 K 576 K

Total Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - 40 K - - - 126 K - - - - - - - 640 K - - - - - - - - - - 379 K 379 K 379 K 379 K 379 K 379 K 379 K 379 K 379 K 379 K 379 K 779 779 K 779 779 K 923 K 923 K - -

Retained Earnings

-426 M -420 M -409 M -405 M -400 M -393 M -386 M -377 M -371 M -362 M -352 M -341 M -330 M -330 M -301 M -289 M -280 M -280 M -265 M -258 M -251 M -251 M -233 M -224 M -216 M -207 M -205 M -197 M -190 M -190 M -175 M -168 M -162 M -162 M -148 M -144 M -139 M -139 M -126 M -120 M -114 M -114 M -98.4 M -91.7 M -86.9 M -86.9 M -74.2 K -69.7 M -65.7 M -65.7 M -57.4 M -55.4 M -51 M -51 M

Total Assets

35.4 M 39.5 M 41.6 M 44.5 M 50.8 M 56.2 M 59.9 M 59.8 M 68.1 M 79.1 M 81.2 M 83.7 M 93.5 M 93.5 M 52.3 M 59 M 65.5 M 65.5 M 24.9 M 27.6 M 31.3 M 31.3 M 24.3 M 30.9 M 39 M 43 M 44.7 M 31 M 37.5 M 37.5 M 32.3 M 40.2 M 45.9 M 45.9 M 56 M 60.3 M 68.2 M 68.2 M 58.3 M 63.8 M 74 M 74 M 71.3 M 65.5 M 68.3 M 68.3 M 79.1 K 81.4 M 47.4 M 47.4 M 49.6 M 49.8 M 46 M 46 M

Cash and Cash Equivalents

3.2 M 6.78 M 5.47 M 5.25 M 5.36 M 3.68 M 8.82 M 10 M 9.77 M 24.9 M 19.2 M 15.2 M 31.8 M 31.2 M 7.82 M 6.62 M 8.27 M 8.27 M 7.3 M 3.72 M 4.11 M 4.11 M 6.8 M 8.43 M 8.82 M 5.94 M 8.58 M 12.3 M 8.58 M 4.71 M 7.33 M 6.1 M 7.33 M 6.1 M 4.95 M 10.8 M 4.95 M 10.8 M 6.96 M 5.66 M 6.96 M 5.66 M 4.63 M 8.6 M 4.63 M 8.6 M 23.5 M 38.8 M 23.5 K 38.8 M 6.67 K 13.6 M 6.67 M 13.6 M

Book Value

35.4 M 39.5 M 41.6 M 44.5 M 50.8 M 56.2 M 59.9 M 59.8 M 68.1 M 79.1 M 81.2 M 83.7 M 93.5 M 93.5 M 52.3 M 59 M 65.5 M 65.5 M 24.9 M 27.6 M 31.3 M 31.3 M 24.3 M 30.9 M 39 M 43 M 44.7 M 31 M 37.5 M 37.5 M 32.3 M 40.2 M 45.9 M 45.9 M 56 M 60.3 M 68.2 M 68.2 M 58.3 M 63.8 M 74 M 74 M 71.3 M 65.5 M 68.3 M 68.3 M 79.1 K 81.4 M 47.4 M 47.4 M 49.6 M 49.8 M 46 M 46 M

Total Shareholders Equity

-5.28 M 96 K 4.4 M 11 M 13.4 M 19.1 M 25 M 26.9 M 30 M 40.1 M 39.8 M 48.9 M 57.2 M 57.2 M 41.1 M 48.9 M 41.1 M 48.9 M 15.9 M 15.9 M 15.9 M 17.5 M 15.2 M 15.2 M 28.5 M 33.2 M 37 M 24.4 M 37 M 24.4 M 25.1 M 32.9 M 25.1 M 32.9 M 49.3 M 52.3 M 49.3 M 52.3 M 49.1 M 53.7 M 49.1 M 53.7 M 60.8 M 54.8 M 60.8 M 54.8 M 69 M 72.2 M 69 K 37.7 M 40.4 K 40.3 M 40.4 M 40.3 M

All numbers in USD currency